Skip to content
★ Sign in to follow
AL

Annette Louise Such

Executive
Total declarations
18
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€467k

Latest filing published 03 May 2017 for AMGEN INC.

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

Annette Louise Such: trading record in brief

All filings by Annette Louise Such on record concern Amgen Inc. Between 24 April 2015 and 1 May 2017, the trades on record add up to 18 filings.

Every open-market trade on record is a sale: 1 sale worth €467k. Other entries cover 17 share grants.

Most recently, on 3 May 2017, the filings show a share grant in Amgen Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Annette Louise Such

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ◆
    VP, Finance and CAOExecutivesAmgen Inc
    0SEC
    615 shares0Common StockSEC:0001127602-17-016761:0
  • ◆
    VP, Finance and CAOExecutivesAmgen Inc
    6,526 USD11SEC
    40 shares@ US$163.140.8% of flowCommon StockSEC:0001127602-17-015594:0
  • ◆
    VP, Finance and CAOExecutivesAmgen Inc
    7,247 USD11SEC
    44 shares@ US$164.700.9% of flowCommon StockSEC:0001127602-17-015594:1
  • ◆
    VP, Finance and CAOExecutivesAmgen Inc
    6,096 USD11SEC
    38 shares@ US$160.410.8% of flowCommon StockSEC:0001127602-17-015475:0
  • ◆
    VP, Finance and CAOExecutivesAmgen Inc
    25,024 USD11SEC
    156 shares@ US$160.413.1% of flowCommon StockSEC:0001127602-17-015475:1
  • ◆
    VP, Finance and CAOExecutivesAmgen Inc
    88,499 USD12SEC
    533 shares@ US$166.0411.1% of flowCommon StockSEC:0001127602-17-013101:0
  • ◆
    VP, Finance and CAOExecutivesAmgen Inc
    0SEC
    1,408 shares0Common StockSEC:0001127602-17-011108:0
  • ◆
    VP, Finance and CAOExecutivesAmgen Inc
    44,384 USD12SEC
    258 shares@ US$172.035.4% of flowCommon StockSEC:0001127602-16-059443:0
  • ▼
    VP, Finance and CAOExecutivesAmgen Inc
    523,770 USD17SEC
    3,000 shares@ US$174.5963.2% of flowCommon StockSEC:0001127602-16-059443:1
  • ◆
    VP, Finance and CAOExecutivesAmgen Inc
    0SEC
    575 shares0Common StockSEC:0001127602-16-051296:0
  • ◆
    VP, Finance and CAOExecutivesAmgen Inc
    6,702 USD11SEC
    41 shares@ US$163.460.8% of flowCommon StockSEC:0001127602-16-050229:0
  • ◆
    VP, Finance and CAOExecutivesAmgen Inc
    6,364 USD11SEC
    39 shares@ US$163.190.8% of flowCommon StockSEC:0001127602-16-049946:0
  • ◆
    VP, Finance and CAOExecutivesAmgen Inc
    108,796 USD12SEC
    729 shares@ US$149.2413.2% of flowCommon StockSEC:0001127602-16-047741:0
  • ◆
    CAOExecutivesAmgen Inc
    0SEC
    1,926 shares0Common StockSEC:0001127602-16-045133:0
  • ◆
    CAOExecutivesAmgen Inc
    280,026 USD0SEC
    1,631 shares@ US$171.69Common StockSEC:0001127602-15-024178:0
  • ◆
    CAOExecutivesAmgen Inc
    0SEC
    285 shares0Common StockSEC:0001127602-15-015488:0
  • ◆
    CAOExecutivesAmgen Inc
    0SEC
    1,191 shares0Common StockSEC:0001127602-15-015488:1
  • ◆
    CAOExecutivesAmgen Inc
    6,716 USD0SEC
    40 shares@ US$167.91Common StockSEC:0001127602-15-015488:2

18 of 18 declarations